- Report
- April 2024
- 325 Pages
Global
From €5359EUR$5,835USD£4,350GBP
- Report
- October 2024
- 324 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 180 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 194 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 188 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- July 2024
- 140 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- April 2024
- 138 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- April 2024
- 136 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 250 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 179 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 233 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 192 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- August 2024
- 175 Pages
Global
From €2177EUR$2,290USD£1,829GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- May 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- July 2024
- 200 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- December 2024
Global
From €7130EUR$7,500USD£5,990GBP

The Vena Cava Filter market is a segment of the Cardiovascular Devices industry. It is composed of medical devices used to prevent pulmonary embolism, a condition in which a blood clot travels to the lungs. Vena Cava Filters are inserted into the inferior vena cava, the largest vein in the body, to capture and prevent the clot from reaching the lungs. The filters are typically made of stainless steel and are designed to be retrievable, allowing for removal once the risk of pulmonary embolism has passed.
The Vena Cava Filter market is driven by the increasing prevalence of deep vein thrombosis, a condition in which a blood clot forms in the deep veins of the body. This is often caused by prolonged immobility, such as during long-distance travel or hospitalization. The market is also driven by the increasing number of minimally invasive procedures, such as laparoscopic surgery, which require the use of Vena Cava Filters.
Notable companies in the Vena Cava Filter market include Boston Scientific, Cook Medical, and Cordis Corporation. Show Less Read more